Article Detail - JE Part A
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R12 - Effective August 6, 2026
Date Posted: August 6, 2026
This Billing and Coding Article has been revised under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).
Effective Date: Multiple dates
Summary of Changes:
Under Article Text added "Specific tests that have been evaluated for compliance with coverage criteria set in policy (and are thus covered or not covered) can be found in the DEX® registry". Under CPT/HCPCS Codes Group 1: Paragraph added "Single genes and solid tumor panels". Under CPT/HCPCS Codes Group 2: Paragraph added "Hematologic neoplasm panels". Under ICD-10 Codes that Support Medical Necessity Group 1: Paragraph added "Solid tumors". Under ICD-10 Codes that Support Medical Necessity Group 2: Paragraph added "Hematologic neoplasms". This revision is effective 8/6/2026.
Under CPT/HCPCS Codes Group 3: Codes added 81288 and 0138U. This revision is effective 7/3/2022.
Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.